Rosuvastatin in Patients with Elevated C-Reactive Protein

被引：0
|
作者：
Koller, Michael T. [1 ]
Bucher, Heiner C. [1 ]
Steyerberg, Ewout W. [2 ]
机构：
[1] Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland
[2] Erasmus Univ, NL-3000 Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 10期
关键词：
COMPETING RISKS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1041 / 1041
页数：1
相关论文
共 50 条
  • [21] Effect of Rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
    Verma, A
    Ranganna, KM
    Reddy, RS
    Verma, M
    Gordon, NF
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (09): : 1290 - 1292
  • [22] ELEVATED C-REACTIVE PROTEIN-LEVELS
    VERMA, UL
    OBSTETRICS AND GYNECOLOGY, 1984, 63 (06): : 866 - 866
  • [23] C-reactive protein is elevated in bipolar disorder
    Dargel, A. A.
    Tamouza, R.
    Henry, C.
    Kapczinski, F.
    Oliveira, J.
    Godin, O.
    Leboyer, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S390 - S391
  • [24] Thrombosis risk and survival in cancer patients with elevated C-reactive protein
    Kanz, R.
    Vukovich, T.
    Vormittag, R.
    Dunkler, D.
    Ay, C.
    Thaler, J.
    Haselboeck, J.
    Scheithauer, W.
    Zielinski, C.
    Pabinger, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) : 57 - 63
  • [25] ELEVATED SERUM LEVELS OF C-REACTIVE PROTEIN IN HEMODIALYSIS-PATIENTS
    DOCCI, D
    BILANCIONI, R
    BUSCAROLI, A
    BALDRATI, L
    CAPPONCINI, C
    MENGOZZI, S
    TURCI, F
    FELETTI, C
    NEPHRON, 1990, 56 (04): : 364 - 367
  • [26] Elevated C-reactive protein and mortality risk among COPD patients
    Banerjee, Srikanta
    Khubchandani, Jagdish
    Onukogu, Claret
    Okpom, Chukwuemeka
    Johnson, Momo
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2024, 18 (01)
  • [27] Prediction of delirium in critically ill patients with elevated C-reactive protein
    Zhang, Zhongheng
    Pan, Lifei
    Deng, Hongsheng
    Ni, Hongying
    Xu, Xiao
    JOURNAL OF CRITICAL CARE, 2014, 29 (01) : 88 - 92
  • [28] Bayesian Number-Needed-to-Treat Analysis of Rosuvastatin for Prevention of Venous Thromboembolism in Patients with Elevated High Sensitivity C-Reactive Protein
    Lang, Christopher
    Arora, Rohit
    CIRCULATION, 2010, 122 (21)
  • [29] Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein
    MacDonald, Gary P.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (08): : 427 - 436
  • [30] COST-EFFECTIVENESS OF ROSUVASTATIN FOR THE PRIMARY PREVENTION OF VASCULAR EVENTS ACCORDING TO FRAMINGHAM RISK SCORE IN PATIENTS WITH AN ELEVATED C-REACTIVE PROTEIN
    MacDonald, G. P.
    VALUE IN HEALTH, 2010, 13 (03) : A163 - A163
12345